Skip to main content
. 2019 Dec 14;25(46):6743–6751. doi: 10.3748/wjg.v25.i46.6743

Table 2.

Helicobacter pylori eradication success rates and complication rates, n (%)

Eradication rate Tailored therapy using DPO-PCR (n = 50) Empirical bismuth-based quadruple therapy (n = 104) P value
Intention-to-treat analysis 48 (96.0) 98 (94.2) 0.6
Per-protocol analysis 48/50 (96.0) 95/100 (95.0) 0.8

DPO-PCR: Dual priming oligonucleotide polymerase chain reaction.